Universal Historical Balance Sheet
601231 Stock | 16.45 0.52 3.26% |
Trend analysis of Universal Scientific Industrial balance sheet accounts such as Other Current Liab of 3.7 M, Total Current Liabilities of 22.3 B or Total Stockholder Equity of 8.6 B provides information on Universal Scientific's total assets, liabilities, and equity, which is the actual value of Universal Scientific to its prevalent stockholders. By breaking down trends over time using Universal Scientific balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Universal Scientific latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Universal Scientific is a good buy for the upcoming year.
Universal Scientific Inventory |
|
Universal |
About Universal Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Universal Scientific at a specified time, usually calculated after every quarter, six months, or one year. Universal Scientific Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Universal Scientific and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Universal currently owns. An asset can also be divided into two categories, current and non-current.
Universal Scientific Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Universal Scientific assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Universal Scientific books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Universal Scientific balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Universal Scientific Industrial are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most accounts from Universal Scientific's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Universal Scientific current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Universal Scientific Industrial. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Universal Scientific's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Other Liabilities is expected to grow to about 623.8 M, whereas Total Assets are forecasted to decline to about 20 B.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 1.3B | 3.7M | 3.9M | 3.7M | Total Assets | 35.9B | 38.6B | 39.3B | 20.0B |
Universal Scientific balance sheet Correlations
Click cells to compare fundamentals
Universal Scientific Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Universal Scientific balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 21.9B | 31.0B | 35.9B | 38.6B | 39.3B | 20.0B | |
Other Current Liab | 644.6M | 826.9M | 1.3B | 3.7M | 3.9M | 3.7M | |
Total Current Liabilities | 10.9B | 14.9B | 17.6B | 18.7B | 21.2B | 22.3B | |
Total Stockholder Equity | 10.3B | 12.1B | 13.1B | 15.7B | 17.0B | 8.6B | |
Other Liab | 144.8M | 223.2M | 560.4M | 516.6M | 594.1M | 623.8M | |
Retained Earnings | 6.5B | 7.9B | 8.6B | 10.3B | 11.2B | 11.7B | |
Accounts Payable | 7.6B | 11.2B | 11.5B | 11.1B | 10.6B | 6.6B | |
Cash | 6.1B | 6.3B | 6.0B | 7.7B | 11.2B | 11.8B | |
Other Assets | 608.4M | 535.1M | 647.7M | 690.9M | 794.5M | 404.0M | |
Net Receivables | 7.4B | 10.5B | 12.5B | 11.1B | 10.0B | 6.6B | |
Inventory | 4.3B | 6.8B | 9.0B | 10.9B | 8.3B | 4.4B | |
Other Current Assets | 351.4M | 508.5M | 588.2M | 599.9M | 838.4M | 880.3M | |
Total Liab | 11.6B | 18.9B | 22.8B | 22.8B | 22.2B | 11.4B | |
Intangible Assets | 137.3M | 290.4M | 453.5M | 415.1M | 368.3M | 386.7M | |
Property Plant Equipment | 1.6B | 2.5B | 4.0B | 4.8B | 5.5B | 5.8B | |
Net Tangible Assets | 10.1B | 10.9B | 12.1B | 13.9B | 15.9B | 10.9B | |
Other Stockholder Equity | (44.3M) | 6.9M | (91.2M) | 326.3M | 375.2M | 394.0M | |
Deferred Long Term Liab | 301.2M | 286.1M | 250.5M | 227.6M | 204.8M | 227.5M | |
Short Long Term Debt | 1.8B | 375.3M | 2.5B | 4.5B | 4.4B | 4.6B | |
Total Current Assets | 18.2B | 24.6B | 28.5B | 30.9B | 31.0B | 23.3B | |
Non Current Assets Total | 3.7B | 6.4B | 7.4B | 7.7B | 8.3B | 5.6B | |
Non Currrent Assets Other | 75.3M | 89.8M | 136.8M | 124.6M | 68.3M | 81.6M | |
Non Current Liabilities Total | 747.9M | 4.0B | 5.2B | 4.1B | 1.0B | 972.6M | |
Non Current Liabilities Other | 5.0M | 16.3M | 61.3M | 11.0M | 74.9M | 78.6M | |
Common Stock Shares Outstanding | 2.2B | 2.2B | 2.2B | 2.2B | 2.2B | 2.4B | |
Net Invested Capital | 12.1B | 15.4B | 19.8B | 23.6B | 21.4B | 17.7B | |
Net Working Capital | 7.3B | 9.7B | 10.9B | 12.1B | 9.8B | 10.0B | |
Capital Stock | 2.2B | 2.2B | 2.2B | 2.2B | 2.2B | 2.4B |
Currently Active Assets on Macroaxis
Other Information on Investing in Universal Stock
Balance Sheet is a snapshot of the financial position of Universal Scientific at a specified time, usually calculated after every quarter, six months, or one year. Universal Scientific Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Universal Scientific and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Universal currently owns. An asset can also be divided into two categories, current and non-current.